Bridging the Gap in Breast Cancer Dormancy: Models, Mechanisms, and Translational Challenges
Pharmaceuticals · 26.06.2025 · 18 (7) · 961
DOI: 10.3390/ph18070961 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 26.06.2025. Verfasst von Hussein Sabit und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology, College of Biotechnology, Misr University for Science and Technology, P.O. Box 77, Giza 3237101, Egypt. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 282 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Breast cancer (BC) poses a significant clinical challenge due to late metastatic recurrence, driven by dormant disseminated tumor cells (DTCs). This review emphasizes the urgency of addressing tumor dormancy to reduce metastatic relapse, a major contributor to BC mortality. DTCs evade conventional therapies and immune surveillance, reactivating unpredictably, thus necessitating targeted strategies. Current research is fragmented, with conflicting data, inadequate models, and a lack of biomarkers hindering progress. This review synthesizes these gaps and proposes actionable priorities, advocating for integrated, standardized approaches. It highlights the roles of single-cell multi-omics, spatial transcriptomics, and humanized long-term models in unraveling dormancy mechanisms. The review also emphasizes macrophage-targeted therapies, dormancy-specific trials, and biomarker validation, offering paths to clinical translation. Ultimately, this work emphasizes the urgent need for integrated multi-omics approaches, including single-cell and spatial transcriptomics, combined with advanced computational analysis. Moreover, this review critically analyzes the existing research landscape, meticulously identifying key gaps, and proposing concrete, forward-looking directions for both fundamental research and clinical translation in the challenging field of BC dormancy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Biotechnology, College of Biotechnology, Misr University for Science and Technology, P.O. Box 77, Giza 3237101, Egypt.
- Department of Environmental Biotechnology, College of Biotechnology, Misr University for Science and Technology, P.O. Box 77, Giza 3237101, Egypt.
- Ministry of Health, Alahsa 39182, Saudi Arabia.
- Oral Biology Department, Faculty of Dentistry, Galala University, Galala Plateau, Attaka, Suez 15888, Egypt.
- University Hospital of Leicester NHS Trust, Leicester LE5 4PW, UK.
- Department of Internal Medicine, Hospital of the Universities of Giessen and Marburg (UKGM), Justus Liebig University Giessen, Feulgenstr. 12, 35392 Giessen, Germany.
ORCID-Profile: Hussein Sabit, Shaimaa Abdel-Ghany, Borros Arneth
Zitieren
APA
Sabit, H., Abdel-Ghany, S., Albrahim, Y., Wadan, A. S., Rashwan, S., Arneth, R., & Arneth, B. (2025). Bridging the Gap in Breast Cancer Dormancy: Models, Mechanisms, and Translational Challenges. Pharmaceuticals, 18(7), 961. https://doi.org/10.3390/ph18070961
Vancouver
Sabit H, Abdel-Ghany S, Albrahim Y, Wadan AS, Rashwan S, Arneth R, et al. Bridging the Gap in Breast Cancer Dormancy: Models, Mechanisms, and Translational Challenges. Pharmaceuticals. 2025;18(7):961. doi:10.3390/ph18070961
BibTeX
@article{Sabit2025,
author = {Sabit, Hussein and Abdel-Ghany, Shaimaa and Albrahim, Yasser and Wadan, Al-Hassan Soliman and Rashwan, Sanaa and Arneth, Rebekka and Arneth, Borros},
title = {Bridging the Gap in Breast Cancer Dormancy: Models, Mechanisms, and Translational Challenges},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {7},
pages = {961},
doi = {10.3390/ph18070961}
}
EUVIMED